Thermo Fisher is facing macro headwinds, but execution remains solid. Click here to read why I’m maintaining my Buy rating for TMO stock.

JP Morgans latest outlook on MSCI India earnings growth estimates signals a positive trend in sectoral earnings per share ...

JP Morgan's latest outlook on MSCI India earnings growth estimates signals a positive trend in sectoral earnings per share ...

Companies such as ABB India, Fine Organics and Jupiter Hospitals delivered less-than-expected Q4 earnings. UPL beat the ...

Confession season has kicked off with relatively little fuss. Here are the stocks Macquarie thinks are offering good upside ...

A thawing in the U.S./China trading relationship is excellent news for a company like GE HealthCare Technologies (NASDAQ: ...

Lyft generated net income of $2.57 million, or $0.01 per share, which easily beat $0.02 per share loss estimates. Active riders grew 11% to 24.2 million, and rides surged 16% to 218.4 million, marking ...

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...

Discover key insights from NRG Energy's Q1 2025 earnings call, featuring record results, a $12B acquisition, doubled generation capacity & raised ...

Synopsys reported solid adoption metrics for their AI tools, as a U.S. memory company reported a 2x improvement in hardware ...

A study was conducted to examine the prognostic value of invasive and noninvasive assessment in athletes with complex ventricular arrhythmias.

CEO Matt Calkins sees the company's strength in "boring" AI, which can save its customers millions of dollars without the ...